Consensus statement on renal denervation in hypertension by ESC/EAPCINews - Feb. 22, 2023
A clinical consensus document on renal denervation in the management of hypertension was recently published in Eur Heart J. by the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). This document was considered needed by the ESC Council on Hypertension and the EAPCI, as the latest ESC/ESH guidelines on management of hypertension were from 2018 and do not recommend device-based therapies for hypertension for the routine treatment of hypertension. Since that time several studies on renal denervation (including randomized, sham-controlled trials) have been published providing new evidence. These studies demonstrated the efficacy and safety of radiofrequency and ultrasound renal denervation in a broad range of patients with hypertension including resistant hypertension.
An expert group provides consensus statements for the use of renal denervation as an additional treatment option for patients with uncontrolled resistant hypertension or for those who are unable to tolerate antihypertensive therapy in the long term. Other conditions need to be in place before renal denervation can be considered, including a shared decision-making process, presence of multidisciplinary hypertension teams, interventionalists with expertise in renal interventions and specific training, and the center needs to fulfill certain requirements.